148 related articles for article (PubMed ID: 32690116)
1. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
[TBL] [Abstract][Full Text] [Related]
2. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
[TBL] [Abstract][Full Text] [Related]
3. Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.
Brouns C; Douven R; Kemp R
Health Econ; 2021 Apr; 30(4):803-819. PubMed ID: 33502788
[TBL] [Abstract][Full Text] [Related]
4. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
Boonen LH; Schut FT
Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
[TBL] [Abstract][Full Text] [Related]
5. Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company.
Bes RE; Curfs EC; Groenewegen PP; de Jong JD
BMC Health Serv Res; 2018 Nov; 18(1):832. PubMed ID: 30400978
[TBL] [Abstract][Full Text] [Related]
6. Competition policy for health care provision in the Netherlands.
Schut FT; Varkevisser M
Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
[TBL] [Abstract][Full Text] [Related]
7. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
Victoor A; Brabers AEM; van Esch TEM; de Jong JD
PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
[TBL] [Abstract][Full Text] [Related]
8. Market competition and price of disease management programmes: an observational study.
van Dijk CE; Venema B; de Jong JD; de Bakker DH
BMC Health Serv Res; 2014 Oct; 14():510. PubMed ID: 25359224
[TBL] [Abstract][Full Text] [Related]
9. Acceptance of selective contracting: the role of trust in the health insurer.
Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
[TBL] [Abstract][Full Text] [Related]
10. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition.
Bes RE; van den Berg B
Patient; 2013; 6(2):75-80. PubMed ID: 23549928
[TBL] [Abstract][Full Text] [Related]
11. Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators.
Portrait FR; van der Galiën O; Van den Berg B
Health Econ; 2016 Apr; 25(4):408-23. PubMed ID: 25702821
[TBL] [Abstract][Full Text] [Related]
12. "Managed competition" for Ireland? The single versus multiple payer debate.
Mikkers M; Ryan P
BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
[TBL] [Abstract][Full Text] [Related]
13. Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands.
Douven R; Burger M; Schut F
Health Econ Policy Law; 2020 Jul; 15(3):341-354. PubMed ID: 30973119
[TBL] [Abstract][Full Text] [Related]
14. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
Duijmelinck DM; Mosca I; van de Ven WP
Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
[TBL] [Abstract][Full Text] [Related]
15. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
[TBL] [Abstract][Full Text] [Related]
16. Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands.
Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
Health Policy; 2022 Feb; 126(2):122-128. PubMed ID: 35000802
[TBL] [Abstract][Full Text] [Related]
17. Changing roles of health insurers in France, Germany, and the Netherlands: any lessons to learn from Bismarckian systems?
Schut FT; Henschke C; Or Z
Health Econ Policy Law; 2023 Oct; 18(4):362-376. PubMed ID: 37675507
[TBL] [Abstract][Full Text] [Related]
18. Effects of the reform of the Dutch healthcare into managed competition: Results of a Delphi study among experts.
de Vries H; Vahl J; Muris J; Evers S; van der Horst H; Cheung KL
Health Policy; 2021 Jan; 125(1):27-33. PubMed ID: 33189409
[TBL] [Abstract][Full Text] [Related]
19. Low institutional trust in health insurers in Dutch health care.
Maarse H; Jeurissen P
Health Policy; 2019 Mar; 123(3):288-292. PubMed ID: 30635139
[TBL] [Abstract][Full Text] [Related]
20. The relation between trust and the willingness of enrollees to receive healthcare advice from their health insurer.
van der Hulst FJP; Brabers AEM; de Jong JD
BMC Health Serv Res; 2023 Jan; 23(1):52. PubMed ID: 36653840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
